Skip to content
LexBuild

Elanco Animal Health, A Div. of Eli Lilly & Co. et al.; Withdrawal of Approval of NADAs

---
identifier: "/us/fr/01-11071"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Elanco Animal Health, A Div. of Eli Lilly & Co. et al.; Withdrawal of Approval of NADAs"
title_number: 0
title_name: "Federal Register"
section_number: "01-11071"
section_name: "Elanco Animal Health, A Div. of Eli Lilly & Co. et al.; Withdrawal of Approval of NADAs"
positive_law: false
currency: "2001-05-03"
last_updated: "2001-05-03"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "01-11071"
document_type: "notice"
publication_date: "2001-05-03"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "66 FR 22235"
fr_volume: 66
docket_ids:
  - "Docket No. 01N-0183"
effective_date: "2001-05-14"
fr_action: "Notice."
---

#  Elanco Animal Health, A Div. of Eli Lilly & Co. et al.; Withdrawal of Approval of NADAs

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is withdrawing approval of 13 new animal drug applications (NADAs) listed below at the request of the sponsor. In a final rule published elsewhere in this issue of the *Federal Register* , FDA is amending the animal drug regulations by removing the portions reflecting approval of the NADAs.

**DATES:**

Withdrawal of approval is effective May 14, 2001.

**FOR FURTHER INFORMATION CONTACT:**

Pamela K. Esposito, Center for Veterinary Medicine (HFV-210), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-5593.

**SUPPLEMENTARY INFORMATION:**

The following sponsors have requested that FDA withdraw approval of the NADAs listed below because the products are no longer manufactured or marketed:

| Sponsor | NADA Number Product (Drug) | 21 CFR Cite Affected |
| --- | --- | --- |
| Elanco Animal Health, A Div. of Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285 | NADA 12-585 Tylan Injectable (tylosin tartrate) | 522.2640b (000986) |
|  | NADA 15-207 Hyferdex Injection (iron dextran complex) | 522.1183(c) (000986) |
|  | NADA 30-330 Tylocine Sulfa Tablets (sulfadiazine, sulfamerazine, sulfamethazine, tylosin) | not applicable |
|  | NADA 31-962 Tylan plus Neomycin Eye Powder (neomycin sulfate, tylosin) | 524.2640 (000986) |
|  | NADA 40-123 Toptic Ointment (cephalonium, flumethasone, iodochlorhydroxyquin, piperocaine hydrochloride, polymyxin B sulfate) | 524.321 (000986) |
|  | NADA 47-092 Tribodine (ticarbodine) | 520.2460a (000986) |
|  | NADA 47-353 Ferti-Cept (chorionic gonadotropin) | 522.1081(b) (000986) |
|  | NADA 92-602 Cephalothin Discs (cephaloridine) | 529.360 (000986) |
|  | NADA 96-678 Tribodine Capsules (ticarbodine) | 520.2460b (000986) |
| Bioproducts, Inc., 320 Springside Dr., suite 300, Fairlawn, OH 44333-2435 | NADA 93-518 Tylan® 10 Plus (tylosin phosphate) | 558.625(b)(2)  (051359) |
| Young’s Inc., Roaring Spring, PA 16673 | NADA 96-162 Hog Grow-R-Mix-4000, Hog Grow-R-Mix-800 (tylosin phosphate) | 558.625(b)(13) (035393) |
| Veterinary Laboratories, Inc., 12340 Santa Fe Dr., Lenexa, KS 66215 | NADA 42-889 Oxytocin Injection (oxytocin) | 522.1680(b) (000857) |
| Webel Feeds, Inc., R.R. 3, Pittsfield, IL 62363 | NADA 116-196 Webel Tylan Premix (tylosin phosphate) | 558.625(b)(73) (035098) |

Therefore, under authority delegated to the Commissioner of Food and Drugs (21 CFR 5.10), redelegated to the Center for Veterinary Medicine (21 CFR 5.84), and in accordance with § 514.115 *Withdrawal of approval of applications* (21 CFR 514.115), notice is given that approval of NADAs 12-585, 15-207, 30-330, 31-962, 40-123, 42-889, 47-092, 47-353, 92-602, 93-518, 96-162, 96-678, and 116-196, and all supplements and amendments thereto, is hereby withdrawn, effective May 14, 2001.

In a final rule published elsewhere in this issue of the *Federal Register* , FDA is amending the animal drug regulations by removing those portions that reflect approval of the NADAs.

Dated: April 23, 2001.

Linda Tollefson,

Deputy Director, Center for Veterinary Medicine.